JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, published by Taylor & Francis Inc, is a pivotal platform for disseminating cutting-edge research in the field of liquid chromatography and its applications across various disciplines including analytical chemistry, biochemistry, and pharmaceutical science. With an ISSN of 1082-6076 and an E-ISSN of 1520-572X, this journal serves as an essential resource for researchers, professionals, and students committed to advancing the understanding and development of chromatographic techniques. Despite not being an open access publication, the journal features a robust submission process from 1996 to 2024, ensuring comprehensive coverage of historical and contemporary methodologies. Notably, it has achieved rankings in the Q3 and Q4 quartiles across various categories, reflecting its reputable position in the field. It’s recognized within key databases, with Scopus ranks indicating its influential role in areas such as pharmaceutical science and analytical chemistry. This journal is not only a cornerstone for specialized studies but also fosters interdisciplinary collaborations, making it an invaluable asset for the scientific community.

JPC-JOURNAL OF PLANAR CHROMATOGRAPHY-MODERN TLC, published by Springer Heidelberg, is a pivotal resource in the fields of Analytical Chemistry, Biochemistry, and Clinical Biochemistry. With an ISSN of 0933-4173 and an E-ISSN of 1789-0993, this journal serves as an essential platform for the dissemination of innovative research on planar chromatography techniques, specifically modern thin-layer chromatography (TLC). With its upcoming coverage extending to 2024 and a third quartile ranking (Q3) across major scientific categories in 2023, it addresses the critical advancements and applications in analytical methods. Although it does not offer open access, the journal's rigorous peer-review process ensures high-quality findings that contribute to the progression of these vital scientific disciplines. The journal is located in Heidelberg, Germany, and continues to be a beacon for researchers, professionals, and students who seek to enhance their knowledge and practice in chromatographic techniques.

PHARMAZIE is a prestigious, peer-reviewed journal published by AVOXA-MEDIENGRUPPE DEUTSCHER APOTHEKER GMBH, focusing on the dynamic field of pharmaceutical science since its inception in 1947. With its ISSN 0031-7144 and a current impact factor placing it in the Q2 category of Pharmaceutical Science journals, PHARMAZIE has established itself as a pivotal resource for researchers, practitioners, and students alike. The journal emphasizes the dissemination of high-quality, original research in pharmacology, toxicology, and pharmaceutics, contributing to the advancement of knowledge and innovation in these fields. While currently not open access, the journal maintains a commendable Scopus rank of #94 out of 183 in its category, highlighting its relevance and appeal to the academic community. With a commitment to bridging the gap between research and practical applications, PHARMAZIE plays a crucial role in shaping the future of pharmaceutical practices and policies.

Clinical Pharmacology in Drug Development, published by WILEY, is a distinguished journal dedicated to advancing the field of pharmaceutical science and drug development. With a strong commitment to disseminating cutting-edge research, this journal serves as a crucial platform for professionals, researchers, and students aiming to enhance their understanding of pharmacological principles and innovations in medical therapeutics. Since its inception in 2012, the journal has consistently maintained a noteworthy presence in the academic community, currently achieving a Q2 ranking in both Pharmaceutical Science and Medical Pharmacology categories as of 2023. Although the journal operates under a subscription model, it is highly regarded for its rigorous peer-reviewed publications, offering insights into drug efficacy, safety, and regulatory challenges. Positioned at the intersection of clinical practices and pharmaceutical advancements, Clinical Pharmacology in Drug Development plays an essential role in bridging the gap between scientific research and real-world application, ensuring that the latest therapeutic strategies are optimized for patient care.

Analytical Science and Technology is a prominent journal dedicated to advancing the fields of analytical chemistry and technology, published by the Korean Society for Analytical Science. Based in South Korea, this journal serves as a vital platform for researchers, professionals, and students committed to exploring innovative analytical techniques and methodologies. Although it is classified under Q4 in various subject categories, including Agronomy and Crop Science, Environmental Chemistry, and Pharmacology, the journal aims to provide critical insights and contributions to the scientific community. With ISSN 1225-0163 and E-ISSN 2288-8985, it spans a converged timeline from 2019 to 2024. Despite its current standings in Scopus rankings, the journal is dedicated to improving its visibility and impact through rigorous peer review and high-quality publications, fostering knowledge sharing within its diverse academic fields. Researchers looking for a reliable outlet for their findings are encouraged to consider this journal as it continues to strive for excellence in analytical science.

Drug Metabolism and Disposition is a premier journal published by the American Society for Pharmacology and Experimental Therapeutics, focusing on crucial advancements in the fields of pharmaceutical sciences and pharmacology. Since its inception in 1973, this esteemed journal has established itself as a leading platform for innovative research, earning a prestigious Q1 rating in both Pharmaceutical Science and Pharmacology categories as of 2023. With an impressive Scopus ranking of #52 out of 183 in Pharmaceutical Science and #105 out of 313 in Pharmacology, it occupies a vital place in an increasingly competitive academic landscape. Researchers, professionals, and students alike benefit from its rigorous peer-reviewed articles that delve into drug metabolism processes and their physiological implications, making it an indispensable resource for anyone aiming to advance their understanding of drug disposition and efficacy. This crucial journal contributes significantly to the ongoing dialogue in pharmacology and toxicology, providing insights that help shape future therapeutic strategies and regulatory policies.

The Turkish Journal of Pharmaceutical Sciences, an esteemed publication by GALENOS PUBL HOUSE, has been a prominent platform for research and innovation in the fields of Pharmaceutical Sciences and Molecular Medicine since its inception as an Open Access journal in 2004. Based in Turkey, this journal serves as a vital resource for researchers, professionals, and students keen on exploring the latest advancements in drug development, pharmacology, and therapeutic innovations. With an ISSN of 1304-530X and an E-ISSN of 2148-6247, the journal is indexed in leading databases and has demonstrated strong rankings in the Scopus index, notably securing the second quartile in Pharmaceutical Sciences. Furthermore, it fosters academic collaboration and knowledge dissemination by making its content freely accessible. The journal aims to inspire groundbreaking research, providing an important academic forum for the dissemination of valuable insights that impact the pharmaceutical sector and contribute to global health.

The European Journal of Pharmaceutical Sciences is a prestigious academic journal dedicated to advancing the field of pharmaceutical science. Published by Elsevier, the journal boasts an impressive impact factor and is categorized in the Q1 quartile for pharmaceutical science as of 2023, signifying its influence and reputation within the academic community. With a Scopus ranking of #20 out of 183 in the fields of pharmacology, toxicology, and pharmaceutics, the journal provides a vital platform for researchers and practitioners to disseminate innovative studies and groundbreaking research that push the boundaries of drug development and delivery. Based in the Netherlands and operating since 1993, the journal seeks to cover a broad scope of topics related to pharmaceutical sciences, encouraging rigorous evaluations and discussions that enhance the understanding and application of this critical field. The absence of open access underscores the commitment to maintaining high scholarly standards, while still offering avenues for libraries and institutions to provide access to cutting-edge research. As the journal converges towards its 2024 milestones, it continuously aims to foster a vibrant exchange of knowledge among its diverse readership, comprising committed researchers, professionals, and students.

ACTA PHARMACEUTICA is a distinguished open-access journal published by SCIENDO, dedicated to advancing knowledge in the fields of medicine and pharmaceutical sciences. Established in 1992, the journal has made significant contributions to the scholarly community, providing a platform for innovative research and discussion. With a strong presence in both Q2 and Q3 quartiles across various categories including Pharmaceutical Science and Pharmacology, ACTA PHARMACEUTICA ranks favorably, positioning its contributions in the upper tiers of the field. The journal's commitment to open access since 2007 ensures that both practitioners and scholars have immediate access to cutting-edge developments, thereby fostering collaboration and knowledge sharing. With its scope spanning a broad spectrum of pharmaceutical and biomedical research, ACTA PHARMACEUTICA is an essential resource for researchers, professionals, and students keen to stay abreast of the latest advancements and trends in these vital areas of study.

The Journal of Pharmaceutical and Biomedical Analysis, published by ELSEVIER and available in print and online formats, stands as a pivotal source of knowledge in the realms of Analytical Chemistry, Clinical Biochemistry, Drug Discovery, and Pharmaceutical Science. With an ISSN of 0731-7085 and an e-ISSN of 1873-264X, this journal is dedicated to publishing high-quality research that advances the understanding and development of analytical techniques in pharmaceuticals and biomedicine. The journal has earned a solid reputation, reflected in its Q2 category rankings across five distinct fields for 2023, and boasts impressive Scopus rankings, signaling its robust impact within the academic community. The Journal of Pharmaceutical and Biomedical Analysis serves as an essential resource for researchers, professionals, and students alike, providing actionable insights and fostering innovation that can directly influence future advancements in drug development and biomedical applications.